Facilitated By

San Antonio Medical Foundation

A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC(PART A) FOLLOWED BY OPEN-LABEL, MULTIPLE-TREATMENT WITH MYOBLOC (PART B) IN THE TREATMENT OF TROUBLESOME SIALORRHEA IN ADULT SUBJECTS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Jackson,Carlayne E
Funded by
SOLSTICE NEUROSCIENCES
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Neuroscience